市场展望:
母乳植入市场 规模在2022年超过了15.9亿美元,并准备达到83.7亿美元,在2023年至2030年期间以23.9%以上的CAGR增长。 推动这一市场的因素包括:妇女对各种化妆工艺的认识得到提高、外科技术的进步以及对乳房增生手术的需求日益增加等。 乳房植入的市场估值预计在今后几年将达到可观值。
Base Year Value (2022)
USD 15.9 Billion
18-23
x.x %
24-33
x.x %
CAGR (2023-2030)
23.9%
18-23
x.x %
24-33
x.x %
Forecast Year Value (2030)
USD 83.7 Billion
18-23
x.x %
24-33
x.x %
Historical Data Period
2018-2021
Largest Region
North America
Forecast Period
2023-2030
Get more details on this report -
市场动态 :
增长动力:
- 日益普及: 乳房增生程序越来越受欢迎,因为妇女寻求提高外表,导致对乳房植入的需求激增。
- 技术进步: 创新外科技术的发展,例如使用安全性能得到改进并具有自然外观效果的植入技术,正在推动乳房植入市场的成长.
- 提高认识:通过各种媒体渠道和因特网,提高妇女对乳房增生程序在美学方面的益处的认识,有助于市场增长。
- 社会文化因素:改变社会规范和偏好,使身体形状更具有审美性,大大地影响了对乳房植入的需求。
(原始内容存档于2017-03-29) (英语). andnbsp;
工业限制和挑战:
- 监管关切:政府机构实施的严格条例和审批程序可能阻碍乳房植入市场的成长。 关于植入物的长期影响的安全关切和定期后续访问的必要性,对制造商和保健专业人员构成了挑战。
- 高成本:乳房增生程序可能昂贵,限制了市场对成本意识的个人的准入。 此外,植入和相关的外科手术费用可能成为市场增长的障碍。
- 手术风险: 与任何外科手术有关的固有风险,如感染、疤痕、植入破裂以及恢复期间的并发症,对广泛采用乳房植入方法构成挑战。
尽管存在这些挑战,由于寻求化妆品强化的个人的需求不断增加,以及不断开发更安全和更先进的植入技术,乳房植入市场预计将继续增长。 制造商和保健专业人员必须继续优先考虑病人的安全,并解决与植入乳房有关的关切和挑战,以确保可持续的市场增长。
Report Coverage & Deliverables
Historical Statistics
Growth Forecasts
Latest Trends & Innovations
Market Segmentation
Regional Opportunities
Competitive Landscape
区域预测:
预计今后几年,包括北美、亚太和欧洲在内的各区域的乳房植入市场将出现显著增长。
北美
由于对化妆品程序和先进的保健基础设施的需求不断增加,预计北美将在预测期间主导市场。 人们对乳房美学的认识不断提高以及该区域主要市场参与者的存在,进一步助长了其市场支配地位。
亚太
由于中国和印度等国家越来越多地采用乳房植入和可支配收入增加,亚太区域预计将出现大幅增长。
欧洲
欧洲在乳房植入市场中也占有很大份额,因为乳房增生手术和优惠补偿政策越来越多。
Get more details on this report -
分块分析:
1. 联合国 硅酮乳植:
硅酮乳腺植入物是乳腺植入物的一个子部分,它作为填充材料含有厚而有凝聚力的硅酮凝胶. 这些植入物比起盐碱植入物提供了更自然的外观和感觉. 寻求乳房增生手术的妇女越来越偏好植入硅酮,这正在催化这一部分的增长。 此外,硅酮植入技术的进步,如开发出形态稳定或"美味熊"和"nbsp;植入能提供更好的稳定性并降低破裂风险,从而被患者和外科医生广泛采用.
2. 盐乳植入:
盐酸乳腺植入是乳腺植入的又一子部分,由一硅酮外壳被无菌的盐酸溶液填充而成. 这些植入物因其在外科手术中的成本效益和可调节体积而出名. 萨林植入物为寻求乳房增生的妇女,特别是那些担心硅酮植入物安全的妇女提供了另一种选择. 由于对负担得起的植入物的需求不断增长,以及各种尺寸和形状的提供,以满足患者个人的需要,这一部分得以推动。
Get more details on this report -
竞争性景观 :
乳房植入市场的竞争环境包括几个关键角色,他们正在努力通过合并和收购、产品发布和协作等战略举措加强其市场地位。 市场上的一些著名角色包括:
1. 联合国 阿尔勒干 PLC:
Allergan PLC是乳房植入市场的主要玩家,通过它的Natrelle品牌提供广泛的植入. 公司注重技术进步和创新,提供优质,安全,可靠的乳房植入. Allergan PLC的强大分销网络,已建立的市场存在,以及广泛的产品组合,促进了其在行业的竞争优势.
2. 锡安特拉公司:
Sientra Inc.是一家著名的乳房植入制造商,强调病人的安全和满意程度. 公司提供包括硅酮和盐碱选择在内的全面的乳腺植入,以及其专有乳腺组织扩张器等创新技术. 西安特拉致力于产品质量,临床卓越,以及客户支持,增强了其在竞争性市场中的地位.
3. 约翰逊和约翰逊:
约翰逊和约翰逊通过其子公司"环球导师"LLC,是乳房植入市场的关键角色. 该公司提供多种具有先进特征的乳房植入物,包括有凝聚力的凝胶填充植入物和组织扩张器. 约翰逊和约翰逊在全球的广泛存在,强大的研发能力,以及强健的营销策略,都促进了其在市场上的竞争优势.
4.四. GC美学:
GC美学是全球乳腺植入的制造商和经销商,为90多个国家的客户服务. 该公司的创新产品组合,包括在Nagor和Eurosilicone品牌下由硅酮填充而成的植入物,使其能够满足整形外科医生和病人的具体需要. GC美学对安全、质量和以病人为中心的解决方案的承诺进一步巩固了它在市场上的地位。
5 (韩语). 机构实验室控股公司:
Institution Labs Holdings Inc.)是乳房植入市场中成长迅速的玩家,专门从事高级硅酮填充乳房植入的设计和制造. 该公司的"Motiva Implanters"提供了一系列先进的特征,如可控纳米纹理等,促进了美学成果和病人的满意. 机构实验室注重创新、强大的分销网络和战略伙伴关系,促进了其在市场上的竞争增长。
最后,乳房植入市场在各区域都有显著增长,北美、亚太和欧洲正在成为主要市场。 市场部门包括硅酮和盐碱乳房植入,每个部门都照顾病人的不同喜好和需要。 市场的竞争面貌以著名角色为特征,如Allergan PLC,Sientra Inc.,Johnson and Johnson,GC美学,和Institution Labs控股公司等,他们努力提供创新解决方案并巩固其市场存在.
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Implant Shape
1.1.3. Application
1.1.4. End-use
1.1.5. Country scope
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Snapshot
Chapter 3. Breast Implants Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Breast Implants Market Analysis Tools
3.4.1. Industry analysis – Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
3.4.3. Major deals & strategic alliances analysis
Chapter 4. Breast Implants Market by Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Silicone Breast Implants
4.1.2. Saline Breast Implants
4.2. Product Market Share, 2022 & 2030
4.3. Segment Dashboard
4.4. Global Breast Implants Market by Product Outlook
4.4.1. Silicone Breast Implants
4.4.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
4.4.2. Saline Breast Implants
4.4.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 5. Breast Implants Market: By Implant Shape Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Round
5.1.2. Anatomical
5.2. By Implant Shape Market Share, 2022 & 2030
5.3. Segment Dashboard
5.4. Global Breast Implants Market by Implant Shape Outlook
5.4.1. Round
5.4.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.4.2. Anatomical
5.4.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 6. Breast Implants Market: By Application Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Reconstructive Surgery
6.1.2. Cosmetic Surgery
6.2. Application Market Share, 2022 & 2030
6.3. Segment Dashboard
6.4. Global Breast Implants market by Application Outlook
6.4.1. Reconstructive Surgery
6.4.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.4.2. Cosmetic Surgery
6.4.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 7. Breast Implants Market: By End-use Estimates & Trend Analysis
7.1. Definitions and Scope
7.1.1. Hospitals
7.1.2. Cosmetology Clinics
7.1.3. Ambulatory Surgical Centers
7.2. End-use Market Share, 2022 & 2030
7.3. Segment Dashboard
7.4. Global Breast Implants Market by End-use Outlook
7.4.1. Hospitals
7.4.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.4.2. Cosmetology Clinics
7.4.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.4.3. Ambulatory Surgical Centers
7.4.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 8. Breast Implants Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2022 & 2030
8.2. County Market Dashboard
8.3. Regional Market Snapshot
8.4. Regional Market Share and Leading Players, 2022
8.4.1. North America
8.4.2. Europe
8.4.3. Asia Pacific
8.4.4. Latin America
8.4.5. Middle East and Africa
8.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
8.5.1. North America
8.5.2. Europe
8.5.3. Asia Pacific
8.5.4. Latin America
8.5.5. Middle East and Africa
8.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030:
8.7. North America
8.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
8.7.2. U.S.
8.7.2.1. Key Country Dynamics
8.7.2.2. Regulatory Structure/Reimbursement Scenario
8.7.2.3. Competitive Scenario
8.7.2.4. Market estimates and forecast, 2018 - 2030 (USD Million)
8.7.3. Canada
8.7.3.1. Key Country Dynamics
8.7.3.2. Regulatory Structure/Reimbursement Scenario
8.7.3.3. Competitive Scenario
8.7.3.4. Market estimates and forecast, 2018 - 2030 (USD Million)
8.8. Europe
8.8.1. Market estimates and forecast, 2018 - 2030 (USD Million)
8.8.2. U.K.
8.8.2.1. Key Country Dynamics
8.8.2.2. Regulatory Structure/Reimbursement Scenario
8.8.2.3. Competitive Scenario
8.8.2.4. Market estimates and forecast, 2018 - 2030 (USD Million)
8.8.3. Germany
8.8.3.1. Key Country Dynamics
8.8.3.2. Regulatory Structure/Reimbursement Scenario
8.8.3.3. Competitive Scenario
8.8.3.4. Market estimates and forecast, 2018 - 2030 (USD Million)
8.8.4. France
8.8.4.1. Key Country Dynamics
8.8.4.2. Regulatory Structure/Reimbursement Scenario
8.8.4.3. Competitive Scenario
8.8.4.4. Market estimates and forecast, 2018 - 2030 (USD Million)
8.8.5. Italy
8.8.5.1. Key Country Dynamics
8.8.5.2. Regulatory Structure/Reimbursement Scenario
8.8.5.3. Competitive Scenario
8.8.5.4. Market estimates and forecast, 2018 - 2030 (USD Million)
8.8.6. Spain
8.8.6.1. Key Country Dynamics
8.8.6.2. Regulatory Structure/Reimbursement Scenario
8.8.6.3. Competitive Scenario
8.8.6.4. Market estimates and forecast, 2018 - 2030 (USD Million)
8.8.7. Denmark
8.8.7.1. Key Country Dynamics
8.8.7.2. Regulatory Structure/Reimbursement Scenario
8.8.7.3. Competitive Scenario
8.8.7.4. Market estimates and forecast, 2018 - 2030 (USD Million)
8.8.8. Sweden
8.8.8.1. Key Country Dynamics
8.8.8.2. Regulatory Structure/Reimbursement Scenario
8.8.8.3. Competitive Scenario
8.8.8.4. Market estimates and forecast, 2018 - 2030 (USD Million)
8.8.9. Norway
8.8.9.1. Key Country Dynamics
8.8.9.2. Regulatory Structure/Reimbursement Scenario
8.8.9.3. Competitive Scenario
8.8.9.4. Market estimates and forecast, 2018 - 2030 (USD Million)
8.9. Asia Pacific
8.9.1. Market estimates and forecast, 2018 - 2030 (USD Million)
8.9.2. Japan
8.9.2.1. Key Country Dynamics
8.9.2.2. Regulatory Structure/Reimbursement Scenario
8.9.2.3. Competitive Scenario
8.9.2.4. Market estimates and forecast, 2018 - 2030 (USD Million)
8.9.3. China
8.9.3.1. Key Country Dynamics
8.9.3.2. Regulatory Structure/Reimbursement Scenario
8.9.3.3. Competitive Scenario
8.9.3.4. Market estimates and forecast, 2018 - 2030 (USD Million)
8.9.4. India
8.9.4.1. Key Country Dynamics
8.9.4.2. Regulatory Structure/Reimbursement Scenario
8.9.4.3. Competitive Scenario
8.9.4.4. Market estimates and forecast, 2018 - 2030 (USD Million)
8.9.5. Australia
8.9.5.1. Key Country Dynamics
8.9.5.2. Regulatory Structure/Reimbursement Scenario
8.9.5.3. Competitive Scenario
8.9.5.4. Market estimates and forecast, 2018 - 2030 (USD Million)
8.9.6. South Korea
8.9.6.1. Key Country Dynamics
8.9.6.2. Regulatory Structure/Reimbursement Scenario
8.9.6.3. Competitive Scenario
8.9.6.4. Market estimates and forecast, 2018 - 2030 (USD Million)
8.9.7. Thailand
8.9.7.1. Key Country Dynamics
8.9.7.2. Regulatory Structure/Reimbursement Scenario
8.9.7.3. Competitive Scenario
8.9.7.4. Market estimates and forecast, 2018 - 2030 (USD Million)
8.10. Latin America
8.10.1. Market estimates and forecast, 2018 - 2030 (USD Million)
8.10.2. Brazil
8.10.2.1. Key Country Dynamics
8.10.2.2. Regulatory Structure/Reimbursement Scenario
8.10.2.3. Competitive Scenario
8.10.2.4. Market estimates and forecast, 2018 - 2030 (USD Million)
8.10.3. Mexico
8.10.3.1. Key Country Dynamics
8.10.3.2. Regulatory Structure/Reimbursement Scenario
8.10.3.3. Competitive Scenario
8.10.3.4. Market estimates and forecast, 2018 - 2030 (USD Million)
8.10.4. Argentina
8.10.4.1. Key Country Dynamics
8.10.4.2. Regulatory Structure/Reimbursement Scenario
8.10.4.3. Competitive Scenario
8.10.4.4. Market estimates and forecast, 2018 - 2030 (USD Million)
8.11. Middle East & Africa
8.11.1. Market estimates and forecast, 2018 - 2030 (USD Million)
8.11.2. South Africa
8.11.2.1. Key Country Dynamics
8.11.2.2. Regulatory Structure/Reimbursement Scenario
8.11.2.3. Competitive Scenario
8.11.2.4. Market estimates and forecast, 2018 - 2030 (USD Million)
8.11.3. Saudi Arabia
8.11.3.1. Key Country Dynamics
8.11.3.2. Regulatory Structure/Reimbursement Scenario
8.11.3.3. Competitive Scenario
8.11.3.4. Market estimates and forecast, 2018 - 2030 (USD Million)
8.11.4. UAE
8.11.4.1. Key Country Dynamics
8.11.4.2. Regulatory Structure/Reimbursement Scenario
8.11.4.3. Competitive Scenario
8.11.4.4. Market estimates and forecast, 2018 - 2030 (USD Million)
8.11.5. Kuwait
8.11.5.1. Key Country Dynamics
8.11.5.2. Regulatory Structure/Reimbursement Scenario
8.11.5.3. Competitive Scenario
8.11.5.4. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.2.1. Innovators
9.3. Vendor Landscape
9.3.1. List of key distributors and channel partners
9.3.2. Key customers
9.3.3. Key company market share analysis, 2022
9.3.4. Allergan Plc.
9.3.4.1. Company overview
9.3.4.2. Financial performance
9.3.4.3. Procedure benchmarking
9.3.4.4. Strategic initiatives
9.3.5. GC Aesthetics Plc.
9.3.5.1. Company overview
9.3.5.2. Financial performance
9.3.5.3. Procedure benchmarking
9.3.5.4. Strategic initiatives
9.3.6. Groupe Sebbin SAS
9.3.6.1. Company overview
9.3.6.2. Financial performance
9.3.6.3. Procedure benchmarking
9.3.6.4. Strategic initiatives
9.3.7. Mentor Worldwide LLC
9.3.7.1. Company overview
9.3.7.2. Financial performance
9.3.7.3. Procedure benchmarking
9.3.7.4. Strategic initiatives
9.3.8. Sientra Inc.
9.3.8.1. Company overview
9.3.8.2. Financial performance
9.3.8.3. Procedure benchmarking
9.3.8.4. Strategic initiatives
9.3.9. Polytech Health & Aesthetics GmbH
9.3.9.1. Company overview
9.3.9.2. Financial performance
9.3.9.3. Procedure benchmarking
9.3.9.4. Strategic initiatives
9.3.10. Establishment Labs S.A.
9.3.10.1. Company overview
9.3.10.2. Financial performance
9.3.10.3. Procedure benchmarking
9.3.10.4. Strategic initiatives
9.3.11. Shanghai Kangning Medical Supplies Ltd.
9.3.11.1. Company overview
9.3.11.2. Financial performance
9.3.11.3. Procedure benchmarking
9.3.11.4. Strategic initiatives
9.3.12. Guangzhou Wanhe Plastic Materials Co., Ltd.
9.3.12.1. Company overview
9.3.12.2. Financial performance
9.3.12.3. Procedure benchmarking
9.3.12.4. Strategic initiatives
9.3.13. LABORATOIRES ARION
9.3.13.1. Company overview
9.3.13.2. Financial performance
9.3.13.3. Procedure benchmarking
9.3.13.4. Strategic initiatives
9.3.14. HansBiomed Co. Ltd.
9.3.14.1. Company overview
9.3.14.2. Financial performance
9.3.14.3. Procedure benchmarking
9.3.14.4. Strategic initiatives
章 次 页 次 1. 方法
章 次 页 次 2. 执行摘要
第三章 乳房植入市场 透视
- 市场概况
- 市场驱动和机会
- 市场限制和挑战
- 规范景观
- 生态系统分析
- 技术和创新 展望
- 主要工业发展
- 供应链分析
- 波特的"五力量分析"
- 新因素的威胁
- 威胁代用品
- 工业竞争
- 供应商的谈判权
- 买方的谈判权
- COVID-19 影响
- PESTLE 分析
- 政治风景区
- 经济景观
- 社会景观
- 技术景观
- 法律景观
- 环境景观
- 竞争性景观
第四章 乳房植入市场 按分部分列的统计数据
* 按照报告范围/要求列出的部分
第五章 乳房植入市场 按地区分列的统计数据
*列表不穷
章 次 页 次 6. 公司数据
- 业务概览
- 财务
- 产品提供
- 战略绘图
- 最近的发展
- 区域统治
- SWOT 分析
* 按照报告范围/要求列出的公司清单